Cargando…
CD147: an integral and potential molecule to abrogate hallmarks of cancer
CD147 also known as EMMPRIN, basigin, and HAb18G, is a single-chain type I transmembrane protein shown to be overexpressed in aggressive human cancers of CNS, head and neck, breasts, lungs, gastrointestinal, genitourinary, skin, hematological, and musculoskeletal. In these malignancies, the molecule...
Autores principales: | Nyalali, Alphonce M. K., Leonard, Angela U., Xu, Yongxiang, Li, Huayu, Zhou, Junlin, Zhang, Xinrui, Rugambwa, Tibera K., Shi, Xiaohan, Li, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662318/ https://www.ncbi.nlm.nih.gov/pubmed/38023152 http://dx.doi.org/10.3389/fonc.2023.1238051 |
Ejemplares similares
-
The prognostic value of the preoperative inflammatory index on the survival of glioblastoma patients
por: Shi, Xiaohan, et al.
Publicado: (2022) -
Neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as potential predictive markers of treatment response in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
por: Rugambwa, Tibera K., et al.
Publicado: (2023) -
CD147: a small molecule transporter ancillary protein at the crossroad of multiple hallmarks of cancer and metabolic reprogramming
por: Kendrick, Agnieszka A., et al.
Publicado: (2016) -
Defining the correlation between immune-checkpoint inhibitors-related adverse events and clinical outcomes: a narrative review
por: Abdihamid, Omar, et al.
Publicado: (2021) -
CD147 Mediates 5-Fluorouracil Resistance in Colorectal Cancer by Reprogramming Glycolipid Metabolism
por: Dong, Shuohui, et al.
Publicado: (2022)